Investment Pitches

Pitch Summary:
Kenvue, Inc. is a consumer health company with leading brands like Tylenol, Listerine, and Neutrogena. Spun off from Johnson & Johnson, we see significant opportunities for Kenvue to unlock value by reinvesting in historically underfunded brands, optimizing its cost structure, and improving margins to enhance cash flow. The company’s stock dropped sharply during the period after reports surfaced that a forthcoming U.S. Health and Human Services study would link acetaminophen (Tylenol's active ingredient) to elevated autism risk during pregnancy. We view the market reaction as overdone for several reasons: no new scientific evidence has established a causal link, pregnant women account for less than 1% of Tylenol’s global sales (minimal revenue impact), and similar claims were largely dismissed in litigation in late 2023 (though appeals remain pending). We continue to hold the company in the Fund and will closely monitor Kenvue’s progress.

BSD Analysis:
Kenvue is settling into its post-spin identity as a stable, cash-generative consumer-health business with category-leading brands and a defensible OTC portfolio. While near-term results have been noisy due to inventory normalization and lingering macro pressure in discretionary health, the long-term margin profile remains attractive. Management is executing well on cost initiatives, supply-chain simplification, and brand investment, all of which should expand gross and operating margins as 2025 unfolds. The balance sheet is improving, cash conversion is strong, and the company has clear visibility into steady dividend growth. Despite this, KVUE trades at a discount to consumer-health peers given its limited track record as a standalone entity. As execution stabilizes and brand momentum improves, the setup screens as a low-volatility compounder that the market is undervaluing.

Pitch Summary:
Liberty Broadband Corp. is a holding company with a 26% ownership stake in cable operator Charter Communications and full ownership of GCI, a broadband and wireless provider in Alaska. The investment case remains straightforward: Liberty Broadband’s shares trade at a meaningful discount to the value of its underlying assets— primarily its Charter stake—with a prospective merger between the two companies serving as the principal catalyst for value realization. The stock underperformed during the period, largely reflecting weaker sentiment across the cable sector following Charter’s softer second-quarter earnings update. Demonstrating the potential benefits of a future combination with Charter and a more streamlined corporate structure, Liberty completed the spin-off of its GCI subsidiary into a standalone entity in July. GCI’s shares traded roughly 20% higher following their listing, partially offsetting Liberty’s earlier weakness. Later in the period, Liberty’s shares recovered some ground after the announcement of a definitive merger agreement with Charter. With GCI now independent, Liberty Broadband’s management can focus exclusively on maximizing value from its Charter investment ahead of the merger, while GCI gains autonomy to pursue Alaska-focused growth initiatives.

BSD Analysis:
Liberty Broadband is basically a leveraged, tax-efficient bet on Charter — but the market is treating it like a structurally broken asset instead of a strategic holding company. Yes, cable subscriber growth is slowing, but Charter’s pricing power, cost discipline, and network upgrade plan (especially DOCSIS 4.0) give it far more durability than the dying-cable narrative suggests. Liberty’s structure amplifies Charter’s equity value while buybacks continue to shrink the float in both entities. The discount to NAV remains absurd, driven by sentiment rather than fundamentals, and Malone’s capital-allocation playbook is still very much alive: shrink the float, let cash flow compound, and wait for the market to wake up. Broadband isn’t glamorous, but it’s sticky, high-margin, and hard to disrupt at scale. Liberty Broadband is a rerating waiting to happen once the market stops treating cable like dial-up.

Pitch Summary:
nLIGHT, Inc. is a leading provider of high-power lasers serving the medical, industrial, and increasingly, defense markets. We initially invested in nLight as they transitioned the company to focus on laser defense applications that shield our troops from drones and enemy missiles. This represented new high-value customers to offset commoditized applications in industrial markets overrun by Chinese-manufactured low-cost lasers. During the quarter, investors re-rated the stock higher in recognition of the growing size of nLight’s addressable markets and its leadership position within them. We remain investors after trimming part of the position on strength as part of our disciplined risk management process. :contentReference[oaicite:9]{index=9}

BSD Analysis:
nLIGHT is one of the purest, most misunderstood plays on the coming laser-enabled manufacturing and defense upgrade cycle. The stock trades like a sleepy photonics supplier, but its high-power fiber lasers are exactly what next-gen metal cutting, EV battery production, and directed-energy defense systems require. Defense alone is a multibillion-dollar opportunity — and the Pentagon isn’t window-shopping; they need scalable laser tech now. nLIGHT has the IP, the production capability, and the government foothold to capture that demand. Commercial markets have been sluggish, but once industrial activity rebounds, this company has massive earnings torque because the fixed-cost base is already in place. Balance sheet strength gives nLIGHT the runway to ride out volatility, and the margin profile should expand significantly as defense mix increases. The market’s apathy is your opportunity — this is a small-cap advanced-manufacturing story sitting on a secular tailwind the market is barely pricing in.

Pitch Summary:
Planet Labs, PBC is a satellite and earth imaging company. They image the entire Earth daily with their constellation of proprietary satellites and have a database of more than 15- years of images which they sell as data. The data is analyzed and used for customer applications in defense, agriculture, conservation, and insurance, and is continually expanding to new use cases. We initially invested in 2024, when the stock fell out of favor due to slowing revenue growth in their commercial segment, a casualty of slowing enterprise software spending. We estimated that the stock was trading below our estimate of the value of its assets, including satellites, databases, and net cash. The market was placing little value on the business despite leading technology, a huge addressable market, and a good balance sheet. The stock performed strongly in the quarter due to a favorable market outlook for defense-related companies (while Planet Lab’s defense and government business continued to grow strongly), and improvement in the commercial business. We continue to hold a position in the company as we believe it has significant room to grow in the large potential earth imaging and analysis market. We did, however, reduce our position into strength during the quarter as part of our risk management process. :contentReference[oaicite:8]{index=8}

BSD Analysis:
Planet Labs is the space-data company everyone loves to dismiss as “sci-fi SaaS,” but the business is transitioning into something more serious — a must-have intelligence layer for agriculture, government, ESG compliance, and climate analytics. The constellation is already built, capex is falling, and the incremental cost of selling another subscription is basically zero. The issue has never been the tech — Planet’s imagery is unmatched — it’s been sales execution and converting science projects into recurring revenue. And that’s finally improving. Government contracts are scaling, multi-vertical adoption is broadening, and gross margins are moving where a real software-data platform should sit. The market still treats Planet like a cash-bleeding satellite toy, ignoring the fact that the economic model gets dramatically better as utilization rises. If management keeps tightening execution, the unit economics could flip from “hope” to “inevitable” very quickly. This is a high-risk name, but the asymmetry is huge.

Pitch Summary:
Kornit Digital, Ltd. is a leading provider of digital textile printing solutions, offering a more efficient and sustainable alternative to traditional screen printing for apparel and textiles. Its digitally enabled process requires fewer people, less energy, and less water. We initiated our investment last year after a prolonged stock decline from $180 to below $20, driven by volatile orders and macroeconomic concerns, including elevated interest rates. The stock contributed positively to fund performance last year, as demand stabilized and orders improved, supported in part by the company’s innovative product offerings and go-to-market strategies. However, shares have been weak in 2025 as macro and tariff issues have delayed orders and created uncertainty, but we continue to own the stock. In our experience, the combination of a leading technology, a large emerging addressable market, a strong balance sheet (>$10/share in cash), and reasonable valuation ( 0.7x EV/sales), are good reasons for patience. :contentReference[oaicite:7]{index=7}

BSD Analysis:
Kornit is the digital textile printer that investors abandoned the moment fast fashion slowed… just as the company is finally getting its act together. The shift to on-demand, inventory-light apparel isn’t going away, and Kornit remains one of the only players with industrial-scale tech that avoids waste, reduces labor, and shortens production cycles. After two years of painful resets, channel cleanups, and customer bankruptcies, Kornit now looks leaner, more disciplined, and far more realistic about demand. Margins are creeping back, consumables are ramping, and the high-speed MAX platform gives Kornit a legitimate competitive moat. The market still prices it like a broken growth stock, ignoring that the company’s tech advantage actually strengthened during the chaos. If apparel brands resume even a modest push toward nearshoring and sustainability, Kornit’s operating leverage will show up fast. This is a bruised but far-from-dead digital manufacturing story.

Pitch Summary:
Perrigo Company, plc is the leading in-store brand for consumer wellness and self-care products. The company endured several years of declining earnings due to what we believe was poor capital allocation by its previous management team, which chased growth through acquisitions outside of Perrigo’s core business. Our investment in Perrigo was inspired by a new management team that committed to pursuing realistic, steady growth rates within the core business, and the company delivering improved profitability and returns on capital. The stock underperformed during the quarter as earnings were guided to the low end of the previously given range due to sales and margin headwinds in their recovering infant formula business. While the fundamental difference in the guide down was small, investor patience has worn thin after years of delayed improvement. We continue to hold Perrigo in the portfolio. :contentReference[oaicite:6]{index=6}

BSD Analysis:
Perrigo is a turnaround in progress in the consumer self-care market, now led by a new management team committed to refocusing on its core, stable business. The historical decline in earnings stemmed from poor capital allocation that chased growth through ill-fitting acquisitions outside its core expertise. The current strategy is a disciplined pivot toward realistic, steady growth rates within the core self-care portfolio, emphasizing margin rebuild and higher returns on capital. Although the stock has suffered from investor patience wearing thin after earnings were guided to the low end due to headwinds in the recovering infant formula business, the underlying fundamental plan is on track. Trading at an undemanding valuation versus comparable consumer staples peers, improving ROIC (Return on Invested Capital) is the critical lever that should drive a multi-year re-rating.

Pitch Summary:
The Honest Company, Inc. is a consumer products company specializing in natural baby-care consumables, beauty, and other household supplies. We initially invested in Honest as a contrarian investment opportunity following post-pandemic supply chain disruptions, seeing value in the brand’s authenticity and in its history of growth despite operational challenges. Despite reporting quarterly results above expectations, the stock declined as the company took a cautious approach to guidance for the remainder of the year. We continue to hold our position as we expect that Honest’s strong management team and unique product offering will see growing consumer distribution and growth well into 2026 and beyond. :contentReference[oaicite:5]{index=5}

BSD Analysis:
The Honest Company represents a contrarian recovery arc in the consumer products sector, with the investment thesis built on the enduring value of its authenticity-focused brand equity. The stock's recent decline, despite beating quarterly earnings expectations, was driven by management taking a cautious approach to forward guidance, creating a low-risk entry point. The company is poised for a significant margin expansion driven by supply-chain normalization and an improving mix of higher-margin product sales. Strong management execution is expected to lead to continued shelf gains and distribution wins, which should re-accelerate revenue growth well into 2026 and beyond. With a conservative balance sheet that reduces downside risk, the stock is valued as if the recovery will never materialize, offering substantial upside as growth returns.

Pitch Summary:
Waystar is a leading cloud-based revenue cycle management platform that supports over 30,000 health care organizations, including 16 of the top 20 US hospitals. We initiated a position based on our view that Waystar is well positioned to benefit from the fallout of last year's cyberattack on its largest competitor, Change Healthcare. While provider switching takes time, early signs indicate this shift is underway. Additionally, we believe Waystar stands to gain from integrating AI capabilities into its software, delivering measurable ROI by automating denial management and prior authorizations, helping providers overcome staffing constraints and improve claims performance.

BSD Analysis:
Waystar is a high-growth Revenue Cycle Management (RCM) platform perfectly positioned to capitalize on a competitive disruption and the massive operational leverage from AI adoption. The core thesis is a direct play on the fallout from a major cyberattack on its largest competitor, Change Healthcare, which is driving provider switching toward Waystar's more resilient cloud-based platform. Waystar is aggressively integrating AI capabilities into its software to automate high-friction workflows like denial management and prior authorizations, delivering a measurable return on investment (ROI) to healthcare providers. With a large, sticky installed base that includes 16 of the top 20 US hospitals, its revenues are highly durable, and the competitive dislocation offers an opportunity for accelerated market share gains. This combination of workflow stickiness and AI-driven efficiency supports the bull case for expanding margins and long-term earnings growth.

Pitch Summary:
During the quarter, we initiated new positions in Teledyne Technologies and Waystar. Teledyne provides advanced sensing, transmission and analysis technologies across niche markets, including digital imaging, instrumentation, and aerospace and defense electronics. Its aerospace and defense segment is benefiting from rising global military spending, which is driving demand for high-performance sensors, drones and space systems. Flagship products like nano drones and proprietary sensor technologies position Teledyne well to meet evolving defense needs. The company’s industrial markets are also recovering, supported by trends in automation and testing. Teledyne has consistently generated strong free cash flow, and management has a proven track record of value creation through disciplined M&A. With accelerating defense demand and a rebound in industrial markets, we see potential for mid-teens EPS growth driven by both organic growth and strategic expansion.

BSD Analysis:
Teledyne remains a quiet powerhouse in sensors, imaging, and instrumentation, with a diversified portfolio that generates incredibly stable cash flow across industrial, defense, and scientific end-markets. The FLIR acquisition continues to outperform, unlocking synergies and giving TDY a dominant position in infrared and unmanned-systems imaging. Management’s disciplined M&A playbook—small, accretive, highly strategic deals—has built a portfolio with high switching costs and recurring revenue visibility. While organic growth is moderate, margins stay elite due to relentless cost control and leading positions in niche, critical technologies. The stock often gets overlooked due to its understated profile, but its consistency and return-on-capital track record rival the best in industrial tech. With a clean balance sheet and steady earnings momentum, Teledyne remains a high-quality compounder trading at a reasonable long-term entry point.

Pitch Summary:
Wingstop, a quick-service restaurant franchisor, reported quarterly results that exceeded expectations, but shares declined due to broader weakness across the restaurant industry. We remain confident in key growth initiatives, including expanded national advertising and the rollout of smart kitchen technology. Early results showed this smart kitchen technology has reduced customer service wait times by 40% within weeks of implementation, improving operational efficiency and enhancing the customer experience at minimal cost to franchisees. We are also optimistic about the planned 2026 launch of Wingstop’s loyalty program, designed to enhance customer engagement and encourage repeat business. We added to our position during the quarter.

BSD Analysis:
Wingstop continues to deliver one of the strongest unit-economics stories in restaurants, with digital mix, pricing power, and a capital-light franchise base driving outsized returns. Same-store sales growth remains impressive, and the brand’s marketing and menu discipline have created cult-like customer engagement without diluting margins. The pipeline for new units is robust, and international expansion is beginning to show real traction. Food cost volatility—especially wings—remains the primary swing factor, but Wingstop has managed through commodity cycles better than peers due to scale and menu simplicity. The stock commands a premium multiple, but the underlying algorithm—high-teens systemwide sales growth and expanding margins—still supports it. As franchisee economics strengthen further, WING remains one of the rare restaurant names with genuine multi-year compounding potential.

Pitch Summary:
PROCEPT BioRobotics develops robotic systems for treating benign prostatic hyperplasia and is rapidly expanding in a largely underpenetrated market, supported by strong clinical evidence, improving insurance coverage and superior outcomes. Shares fell despite reporting 55% year-over-year revenue growth and rising margins, due to the unexpected retirement of its CEO. We view the appointment of new CEO Larry Wood, a former Edwards Lifesciences executive, as a meaningful upgrade to lead the company’s next phase of growth.

BSD Analysis:
PROCEPT is one of the cleanest high-growth med-tech stories, with Aquablation rapidly scaling as the first truly differentiated BPH therapy in years. Procedure growth remains exceptional, driven by strong surgeon adoption, clear clinical superiority over legacy thermal and resection techniques, and expanding reimbursement. The razor-razorblade model gives PRCT a long runway of recurring revenue and attractive gross margins as utilization ramps. While the company is still in a heavy investment phase, operating leverage is beginning to emerge, and the payback period for new centers continues to shorten. Competitive risk remains low given Aquablation’s unique safety and efficacy profile. With a massive underpenetrated market and accelerating adoption curves, PROCEPT screens as a long-duration med-tech compounder that the market still undervalues.

Pitch Summary:
London Stock Exchange Group (LSEG) is a leading global provider of market infrastructure and capital markets services. We are attracted to its ability to further monetize its proprietary data, particularly through its early partnership with Microsoft. During the quarter, competitive pressures intensified in the Workstation segment, with rivals—especially FactSet—cutting prices aggressively. While we believe LSEG has responded well and strengthened its offering from a lower price point, these pressures have created short-term headwinds. Additionally, the emergence of advanced AI models, such as Anthropic’s Claude for Financial Services, has raised questions about potential disruption to financial information services. However, we view these large language models more as new distribution channels for LSEG’s proprietary data than as threats to its core business. Despite our continued confidence in the company’s long-term outlook over the next 24 months, these near-term challenges have led us to trim the position.

BSD Analysis:
LSEG is no longer just an exchange — it’s a data and analytics machine with a monopoly-adjacent grip on global finance. The Refinitiv integration was messy, loud, and borderline traumatic, but it created an information powerhouse that rivals Bloomberg in scale and outperforms it in distribution. Now the synergies are showing up exactly where they matter: margins are expanding, recurring revenue dominates, and the Terminal business is starting to look like a serious competitive threat. LSEG’s clearing and index franchises throw off stable cash, and the data business gives it a structural growth runway that most exchanges can only dream about. Yet the market still prices it like a slow, conservative European financial instead of a tech-enabled data infrastructure operator with global reach. As financial institutions continue to consolidate vendors and push for workflow integration, LSEG is positioning itself as the default operating layer. The rerating case here is hiding in plain sight.

Pitch Summary:
Ascendis is a biotech company leveraging its proprietary TransCon™ platform to develop differentiated therapies that address unmet medical needs. This technology enables sustained and predictable drug release while preserving the drug’s original mechanism of action. The launch of Yorvipath®—the first and only hormone replacement therapy for adult hypoparathyroidism—has exceeded expectations, generating revenues of €103 million in Q2 2025, more than double the prior quarter, with over 3,100 patients and 1,500 US prescribers. This strong uptake reinforces our confidence in both Yorvipath® and Ascendis’ broader pipeline.

BSD Analysis:
Ascendis Pharma is what happens when a biotech gets its science right but the market only focuses on every speed bump along the way. SKYTROFA’s launch is gaining traction, the pipeline is stacked with long-acting hormone programs that reduce patient burden, and the company’s TransCon platform is proving it can repeatedly deliver improved pharmacokinetics over standard therapies. Yes, regulatory delays and capital concerns spooked investors, but Ascendis has navigated worse and shown it can execute when it matters. Once the cash burn narrative fades, what’s left is a platform company with multi-billion-dollar potential across endocrinology, oncology, and rare disease. The risk profile is still biotech-normal, but the payoff — if consecutive readouts break their way — is far from priced in. Ascendis is one of those names where sentiment swings wildly, but the underlying science and market need are far more stable than the stock chart suggests.

Pitch Summary:
Pure Storage is redefining enterprise data storage by sourcing raw NAND flash memory and building custom all-flash systems, which enhances cost efficiency. The company is gaining share in core enterprise markets, and its collaboration with SK hynix for hyperscale data center environments supports its efforts to expand its addressable market. During the quarter, Pure Storage reported revenue rose 13% year over year to $861 million, driven by enterprise demand and strong performance in its subscription services and next-generation product portfolio. While cloud and hyperscaler traction are still early, core business metrics remain solid.

BSD Analysis:
Pure Storage has gone from being a “nice-to-have” flash vendor to a full-blown AI infrastructure enabler — and the market is only beginning to price in the shift. Its all-flash arrays are exactly what hyperscalers need as datasets explode and latency tolerance evaporates, and Pure’s subscription-heavy model turns that demand into sticky, high-margin recurring revenue. Competitors are still pushing hybrid storage like it’s 2015, while Pure is delivering performance-per-watt metrics that make legacy arrays look prehistoric. The company’s new FlashBlade and Evergreen architectures offer the kind of scalability AI workloads require, giving Pure a seat at the table with giants it has no business intimidating — yet it does. Free cash flow is accelerating, gross margins are expanding, and the customer win rate in large enterprises is trending in the right direction. This is no longer a niche flash play — it’s a stealth AI infrastructure compounder hiding behind a modest valuation.

Pitch Summary:
Modine is a global leader in thermal management solutions. The company is experiencing strong growth, driven by increased business with existing hyperscale customers and the addition of new accounts in the hyperscale segment. Rising demand across newer geographies, particularly in the US and Southeast Asia, and Modine’s expansion into advanced product lines, such as rack-level and modular data center cooling solutions, have further fueled this momentum. As a result, the company has significantly raised its revenue expectations for the year.

BSD Analysis:
Modine is a scorching-hot, high-conviction bet as a true AI data center picks-and-shovels winner within the thermal management space. The company is experiencing exponential growth fueled by surging demand from hyperscale customers, with new accounts and newer geographies like Southeast Asia accelerating revenue expectations. Its technical expertise in high-value, rack-level and modular cooling solutions is directly tied to the capital intensity of the AI build-out. To meet this unprecedented demand, Modine is committing $100 million in CapEx over 12-18 months to double its capacity by 80%, a move that should guarantee multi-year revenue visibility. Trading at an attractive valuation with an EV/EBITDA of ~9-10x and Net Leverage under 1x, the stock is poised for explosive margin expansion as mix shifts to higher-value systems and scale builds.

Pitch Summary:
Brandes initiated a position in SMC Corporation, the world’s largest manufacturer of pneumatic components with nearly 40% market share. The stock fell 50% from its March 2024 peak due to margin compression and slower growth following capacity expansion. Despite this, SMC retains a strong balance sheet with net cash exceeding 25% of market cap and consistent profitability. The firm’s global scale, product breadth, and distribution network support its competitive moat. Management’s capital discipline, dividend growth, and automation exposure underpin long-term appeal.

BSD Analysis:
SMC remains the gold standard in industrial pneumatics and precision automation, with a scale, distribution network, and product breadth that competitors simply can’t replicate. While global manufacturing softness has weighed on near-term volumes, SMC’s pricing discipline and mix shift toward higher-value components have preserved margins admirably. The company's R&D engine continues to push deeper into electric actuators and advanced motion control, giving it leverage to secular automation trends across semiconductors, life sciences, and logistics. Balance sheet strength provides ample room for strategic investment and opportunistic buybacks, enhancing per-share value. Despite a temporary industrial slowdown, SMC’s long-term algorithm—steady mid-single-digit growth plus elite margin resilience—remains fully intact. As industrial activity stabilizes, SMC should reassert itself as a high-quality compounder trading below its intrinsic consistency premium.

Pitch Summary:
Patrick is a manufacturer and distributor of components and materials for RV, marine, manufactured housing, and residential construction markets that is benefiting from an ongoing outsourcing trend across these end markets. Tariff and inventory concerns caused a pullback in shares to a valuation we found attractive.

BSD Analysis:
Patrick Industries is the underappreciated backbone of the RV and manufactured housing supply chain — the company that gets hit every time the cycle turns but always comes out stronger. After a brutal RV downturn, Patrick has trimmed fat, cleaned up inventory, and doubled down on higher-margin components and aftermarket products. Now, with volumes stabilizing and dealer inventories normalizing, even a modest recovery could drive outsized profitability thanks to the company’s aggressive cost discipline. Management’s M&A engine is still very much alive, targeting niche suppliers with sticky OEM relationships and high cash conversion. The balance sheet is stronger than people realize, and Patrick’s diversified exposure reduces the boom-bust risk investors assume. At its current valuation, the market is pricing in perpetual weakness, ignoring how violently this name can rebound once cycle turns. For investors with a pulse, Patrick is exactly the kind of high-beta cyclical that snaps back harder than consensus ever models.

Pitch Summary:
Montage Technology. The company reported surging revenue and net profit growth, and our research indicated that it has continued to enlarge its presence in the scale-up networking market, while maintaining stable growth in its interface integrated circuit business.

BSD Analysis:
Montage is becoming a quiet force in the semiconductor stack, leveraging its leadership in memory interface ICs and scale-up networking silicon to ride the AI and hyperscale compute wave. Revenue acceleration and surging profit growth show the firm executing well as DDR5, CXL, and high-bandwidth interconnect demand ramp across data centers. Its expanding footprint in switch/accelerator connectivity positions Montage as a core enabler of next-gen server architectures—an area where bottlenecks, not compute, increasingly dictate performance. Operating leverage is improving as new product ramps gain traction and customer adoption widens across both domestic and global manufacturers. Despite these tailwinds, the stock still trades at a discount to peers with similar AI exposure, reflecting outdated assumptions about end-market cyclicality. With structural demand for networking silicon rising, Montage’s growth profile remains underappreciated relative to its strategic positioning.

Pitch Summary:
Delta Electronics. Positive earnings surprises and strong performance in electric vehicles and data centers lifted shares. The company raised earnings forecasts, reflecting confidence in its growth trajectory. We believe Delta, a key supplier of AI power, is benefiting from global electrification trends and AI infrastructure expansion.

BSD Analysis:
Delta Electronics is the power-management powerhouse hiding in plain sight — the company’s components sit inside the data centers, EVs, and industrial systems that make modern electrification possible. As AI data centers guzzle power at unprecedented rates, Delta’s high-efficiency power modules and thermal solutions are becoming mandatory upgrades, not discretionary add-ons. The company’s edge comes from decades of obsessive engineering in power conversion, giving it efficiency wins that hyperscalers care about far more than they admit publicly. EV and industrial automation growth offer additional legs to the story, supported by Delta’s global manufacturing footprint and conservative financial management. Despite its strategic positioning, the stock still trades like a steady industrial rather than a high-leverage AI and electrification supplier. As power density requirements surge, Delta is positioned to capture recurring, high-margin design wins across multiple megatrends. This is the kind of boring-but-critical business that compounds quietly until suddenly it doesn’t look boring anymore.

Pitch Summary:
Arkema underperformed as continued weakness in its Coatings and Intermediates segments pressured margins. The company also underwent a leadership change, which added uncertainty regarding integration of recent acquisitions amid soft global demand.

BSD Analysis:
Arkema is the kind of specialty chemicals name that always trades like a boring industrial… right up until investors realize it’s quietly tied to some of the highest-growth materials markets on the planet. The company’s shift toward adhesives, advanced polymers, and high-performance materials has completely changed its earnings quality — but the market is still valuing it like a cyclical commodity shop. Margin expansion is being driven by specialty products with pricing power, not volume chasing, and Arkema’s portfolio mix is becoming increasingly insulated from raw-material shocks. The balance sheet is clean, capex is disciplined, and management continues to prune low-return businesses in favor of higher-margin engineered materials. With exposure to EVs, batteries, electronics, and next-gen coatings, Arkema is sitting right in the slipstream of multiple secular growth curves. If the specialty pivot continues to execute, the stock’s valuation gap versus U.S. peers is going to look increasingly irrational. This is a stealth compounder hiding inside a French chemical wrapper.